1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2016

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of Arteriotomy Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Arteriotomy Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Arteriotomy Closure Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Arteriotomy Closure Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Arteriotomy Closure Devices - Medical Devices Pipeline Assessment, 2016
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Arteriotomy Closure Devices Overview 7
3 Products under Development 8
3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8
3.2 Arteriotomy Closure Devices - Pipeline Products by Segment 9
3.3 Arteriotomy Closure Devices - Pipeline Products by Territory 10
3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11
3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12
3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials 13
4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies 14
4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development 14
4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development 15
5 Arteriotomy Closure Devices Companies and Product Overview 16
5.1 Aporo Biomedical, Inc. Company Overview 16
5.1.1 Aporo Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 16
5.2 CardioDex Ltd. Company Overview 18
5.2.1 CardioDex Ltd. Pipeline Products and Ongoing Clinical Trials Overview 18
5.3 CloSys Corporation Company Overview 20
5.3.1 CloSys Corporation Pipeline Products and Ongoing Clinical Trials Overview 20
5.4 Cook Medical Incorporated Company Overview 22
5.4.1 Cook Medical Incorporated Pipeline Products and Ongoing Clinical Trials Overview 22
5.5 CPC of America, Inc. Company Overview 23
5.5.1 CPC of America, Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
5.6 Essential Medical LLC Company Overview 25
5.6.1 Essential Medical LLC Pipeline Products and Ongoing Clinical Trials Overview 25
5.7 Harvard University Company Overview 30
5.7.1 Harvard University Pipeline Products and Ongoing Clinical Trials Overview 30
5.8 InSeal Medical Ltd. Company Overview 32
5.8.1 InSeal Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 32
5.9 ProMed, Inc. Company Overview 36
5.9.1 ProMed, Inc. Pipeline Products and Ongoing Clinical Trials Overview 36
5.10 Rex Medical, L.P. Company Overview 37
5.10.1 Rex Medical, L.P. Pipeline Products and Ongoing Clinical Trials Overview 37
5.11 Transluminal Technologies LLC Company Overview 38
5.11.1 Transluminal Technologies LLC Pipeline Products and Ongoing Clinical Trials Overview 38
5.12 University of Rochester Company Overview 40
5.12.1 University of Rochester Pipeline Products and Ongoing Clinical Trials Overview 40
5.13 Vascular Closure Systems, Inc. Company Overview 41
5.13.1 Vascular Closure Systems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 41
5.14 Vascular Solutions, Inc. Company Overview 45
5.14.1 Vascular Solutions, Inc. Pipeline Products and Ongoing Clinical Trials Overview 45
5.15 Vasorum Limited Company Overview 47
5.15.1 Vasorum Limited Pipeline Products and Ongoing Clinical Trials Overview 47
5.16 Vivasure Medical Ltd. Company Overview 51
5.16.1 Vivasure Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 51
6 Arteriotomy Closure Devices- Recent Developments 54
7 Appendix 60
7.1 Methodology 60
7.2 About GlobalData 62
7.3 Contact Us 63
7.4 Disclaimer 63

1.1 List of Tables
Table 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8
Table 2: Arteriotomy Closure Devices - Pipeline Products by Segment 9
Table 3: Arteriotomy Closure Devices - Pipeline Products by Territory 10
Table 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11
Table 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12
Table 6: Arteriotomy Closure Devices - Ongoing Clinical Trials 13
Table 7: Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development 14
Table 8: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 15
Table 9: Aporo Biomedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 16
Table 10: Femoral Artery Closure Device - Product Status 17
Table 11: Femoral Artery Closure Device - Product Description 17
Table 12: CardioDex Ltd. Pipeline Products and Ongoing Clinical Trials Overview 18
Table 13: EpiClose Plus - Product Status 19
Table 14: EpiClose Plus - Product Description 19
Table 15: CloSys Corporation Pipeline Products and Ongoing Clinical Trials Overview 20
Table 16: CloSys HD - Product Status 21
Table 17: CloSys HD - Product Description 21
Table 18: Cook Medical Incorporated Pipeline Products and Ongoing Clinical Trials Overview 22
Table 19: X-Port Vascular Access Closure Device - Product Status 22
Table 20: X-Port Vascular Access Closure Device - Product Description 22
Table 21: CPC of America, Inc. Pipeline Products and Ongoing Clinical Trials Overview 23
Table 22: MedClose - Product Status 24
Table 23: MedClose - Product Description 24
Table 24: Essential Medical LLC Pipeline Products and Ongoing Clinical Trials Overview 25
Table 25: MANTA - Product Status 25
Table 26: MANTA - Product Description 25
Table 27: X-Seal - Product Status 26
Table 28: X-Seal - Product Description 26
Table 29: Essential Medical LLC - Ongoing Clinical Trials Overview 27
Table 30: X-Seal - X-Seal 6F Vascular Closure Device EU Post-market Clinical Follow-up Protocol 28
Table 31: MANTA - Clinical Study to Evaluate the Safety and Performance of MANTA Vascular Closure Device 29
Table 32: MANTA - EU Studies for MANTA Large Bore Vascular Closure Device 29
Table 33: Harvard University Pipeline Products and Ongoing Clinical Trials Overview 30
Table 34: Access-Closure Device - Product Status 31
Table 35: Access-Closure Device - Product Description 31
Table 36: InSeal Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 32
Table 37: InSeal Intravascular Closure Device - Product Status 33
Table 38: InSeal Intravascular Closure Device - Product Description 33
Table 39: InSeal Medical Ltd. - Ongoing Clinical Trials Overview 34
Table 40: InSeal Intravascular Closure Device - InSeal Vascular Closure Device Clinical Study Protocol 35
Table 41: InSeal Intravascular Closure Device - InSeal VCD Large Bore Vascular Closure Device Clinical Study 35
Table 42: ProMed, Inc. Pipeline Products and Ongoing Clinical Trials Overview 36
Table 43: Large Hole Closure Device - Product Status 36
Table 44: Large Hole Closure Device - Product Description 36
Table 45: Rex Medical, L.P. Pipeline Products and Ongoing Clinical Trials Overview 37
Table 46: Auto-Close Vascular Sealing System - Product Status 37
Table 47: Auto-Close Vascular Sealing System - Product Description 37
Table 48: Transluminal Technologies LLC Pipeline Products and Ongoing Clinical Trials Overview 38
Table 49: Velox CD - Product Status 39
Table 50: Velox CD - Product Description 39
Table 51: University of Rochester Pipeline Products and Ongoing Clinical Trials Overview 40
Table 52: Vascular Closure Device - Product Status 40
Table 53: Vascular Closure Device - Product Description 40
Table 54: Vascular Closure Systems, Inc. Pipeline Products and Ongoing Clinical Trials Overview 41
Table 55: FastSeal Bioabsorbable Vascular Access Closure System - Product Status 42
Table 56: FastSeal Bioabsorbable Vascular Access Closure System - Product Description 42
Table 57: FastSeal Self - Closing Nitinol Clip System - Product Status 43
Table 58: FastSeal Self - Closing Nitinol Clip System - Product Description 43
Table 59: FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Status 44
Table 60: FastSeal Swellable And Bioabsorbable Tubular Plug System - Product Description 44
Table 61: Vascular Solutions, Inc. Pipeline Products and Ongoing Clinical Trials Overview 45
Table 62: Magna Seal - Product Status 46
Table 63: Magna Seal - Product Description 46
Table 64: Vasorum Limited Pipeline Products and Ongoing Clinical Trials Overview 47
Table 65: Celt ACD - Product Status 48
Table 66: Celt ACD - Product Description 48
Table 67: Vasorum Limited - Ongoing Clinical Trials Overview 49
Table 68: Celt ACD - Clinical Investigation Plan for Safety and Efficacy Study of Arterial Closure Device (CELT ACD). Clinical Investigation Plan No.: CIP-TS-003 50
Table 69: Vivasure Medical Ltd. Pipeline Products and Ongoing Clinical Trials Overview 51
Table 70: PerQseal - Product Status 51
Table 71: PerQseal - Product Description 51
Table 72: Vivasure Medical Ltd. - Ongoing Clinical Trials Overview 52
Table 73: PerQseal - Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER I Study 53
Table 74: PerQseal - Safety and Performance Study of Large Hole Vascular Closure Device: FRONTIER II Study 53
Table 75: Glossary 61

1.2 List of Figures
Figure 1: Arteriotomy Closure Devices - Pipeline Products by Stage of Development 8
Figure 2: Arteriotomy Closure Devices - Pipeline Products by Segment 9
Figure 3: Arteriotomy Closure Devices - Pipeline Products by Territory 10
Figure 4: Arteriotomy Closure Devices - Pipeline Products by Regulatory Path 11
Figure 5: Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date 12
Figure 6: Arteriotomy Closure Devices - Ongoing Clinical Trials 13

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.